We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

156 hedge funds and large institutions have $281M invested in Alaunos Therapeutics in 2020 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 40 increasing their positions, 53 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more funds holding

Funds holding: 154 → 156 (+2)

8% more call options, than puts

Call options by funds: $2.72M | Put options by funds: $2.51M

8% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 25

4% more capital invested

Capital invested by funds: $270M → $281M (+$11.5M)

0.01% more ownership

Funds ownership: 0.34% → 0.35% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

25% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 53

Holders
156
Holders Change
+2
Holders Change %
+1.3%
% of All Funds
2.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
27
Increased
40
Reduced
53
Closed
25
Calls
$2.72M
Puts
$2.51M
Net Calls
+$207K
Net Calls Change
-$452K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.48M
2
DCM
Discovery Capital Management
Connecticut
+$4.2M
3
JP Morgan Chase
JP Morgan Chase
New York
+$2.09M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.82M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.04M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$4.18M
2
SG Americas Securities
SG Americas Securities
New York
-$1.89M
3
State Street
State Street
Massachusetts
-$1.78M
4
Bank of America
Bank of America
North Carolina
-$838K
5
TRCT
Tower Research Capital (TRC)
New York
-$688K
Name Holding Trade Value Shares
Change 		Change in
Stake
Pacer Advisors
126
Pacer Advisors
Pennsylvania
$28K +$11.1K +28 +60%
SC
127
Scotia Capital
Ontario, Canada
$26K – – –
ODG
128
O'Dell Group
Ohio
$26K +$27K +68 New
BF
129
BOK Financial
Oklahoma
$25K – – –
MFG
130
Magnus Financial Group
New York
$25K – – –
EAM
131
Eagle Asset Management
Florida
$25K +$26.2K +66 New
Macquarie Group
132
Macquarie Group
Australia
$21K – – –
CFA
133
Carroll Financial Associates
North Carolina
$15K – – –
NFSG
134
Newbridge Financial Services Group
Florida
$15K – – –
EPM
135
Equitec Proprietary Markets
Illinois
$13K -$5.17K -13 -28%
LWA
136
Lenox Wealth Advisors
New York
$13K – – –
PNC Financial Services Group
137
PNC Financial Services Group
Pennsylvania
$12K – – –
PCM
138
Penserra Capital Management
California
$12K +$13.1K +33 New
SIAG
139
Safeguard Investment Advisory Group
California
$12K +$13.5K +34 New
GWM
140
Geneos Wealth Management
Colorado
$9K – – –
KFI
141
Key Financial Inc
Pennsylvania
$9K +$9.94K +25 New
OSAM
142
O'Shaughnessy Asset Management
Connecticut
$7K – – –
IAIM
143
International Assets Investment Management
Florida
$7K +$7.16K +18 New
COCM
144
Charter Oak Capital Management
New Hampshire
$6K +$6.76K +17 New
APA
145
American Portfolios Advisors
New York
$3.28K – – –
TWA
146
TCI Wealth Advisors
Arizona
$3K -$795 -2 -22%
JFA
147
JNBA Financial Advisors
Minnesota
$1K – – –
KCM
148
Kathmere Capital Management
Pennsylvania
$1K – – –
MLFP
149
MPS Loria Financial Planners
Illinois
$1K – – –
SBL
150
Sargent Bickham Lagudis
Colorado
$1K +$795 +2 New
4 5
6
7 8

TCRT Hedge Fund Activity: Q4 2020 in Review

156 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q4 2020, worth a combined $281M — up 4.3% from $270M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TCRT positions and 25 closed out — a net gain of 2 holders — while 40 added to existing stakes and 53 trimmed.

The largest buyer was BlackRock, adding an estimated $9.48M. The largest seller was Goldman Sachs, cutting an estimated $4.18M.

  • 156 institutional investors held Alaunos Therapeutics (TCRT) as of Q4 2020, up from 154 in Q3 2020.
  • Funds reported $281M of Alaunos Therapeutics stock for Q4 2020, up 4.3% quarter-over-quarter.
  • 27 funds opened new Alaunos Therapeutics positions in Q4 2020 and 25 closed out, a net change of +2 holders.
  • The largest Alaunos Therapeutics buyer in Q4 2020 was BlackRock, an estimated $9.48M added.
  • The largest Alaunos Therapeutics seller in Q4 2020 was Goldman Sachs, an estimated $4.18M sold.

Based on aggregated 13F filings for Q4 2020.